檢索結果 - Naohiro Oda
- Showing 1 - 8 results of 8
-
1
-
2
Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and rem... 由 Naohiro Oda, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Takahiro Taki, Reo Mitani, Toshiaki Okada, Ichiro Takata
發表在 Clinical Case Reports (2021-07-01)獲取全文
Article -
3
A case of axillary lymphadenitis caused by Mycobacterium intracellulare in an immunocompetent patient 由 Junko Itano, Kadoaki Ohashi, Satoru Senoo, Naohiro Oda, Kazuya Nishii, Akihiko Taniguchi, Nobuaki Miyahara, Yoshinobu Maeda, Katsuyuki Kiura
發表在 Respiratory Medicine Case Reports (2019-01-01)獲取全文
Article -
4
A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. 由 Eiki Ichihara, Kou Hasegawa, Kenichiro Kudo, Yasushi Tanimoto, Kazuhiro Nouso, Naohiro Oda, Sho Mitsumune, Haruto Yamada, Ichiro Takata, Hideharu Hagiya, Toshiharu Mitsuhashi, Akihiko Taniguchi, Shinichi Toyooka, Kohei Tsukahara, Toshiyuki Aokage, Hirokazu Tsukahara, Katsuyuki Kiura, Yoshinobu Maeda
發表在 PLoS ONE (2023-01-01)獲取全文
Article -
5
A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection 由 Eiki Ichihara, Kou Hasegawa, Kenichiro Kudo, Yasushi Tanimoto, Kazuhiro Nouso, Naohiro Oda, Sho Mitsumune, Haruto Yamada, Ichiro Takata, Hideharu Hagiya, Toshiharu Mitsuhashi, Akihiko Taniguchi, Shinichi Toyooka, Kohei Tsukahara, Toshiyuki Aokage, Hirokazu Tsukahara, Katsuyuki Kiura, Yoshinobu Maeda
發表在 PLoS ONE (2023-01-01)獲取全文
Article -
6
Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis 由 Katsuyoshi Tomomatsu, Hirotaka Yasuba, Takashi Ishiguro, Shiro Imokawa, Johsuke Hara, Seiko Soeda, Norihiro Harada, Naomi Tsurikisawa, Naohiro Oda, Shigeki Katoh, Takanori Numata, Yasuteru Sugino, Mitsuhiro Yamada, Mitsuhiro Kamimura, Takeshi Terashima, Naoki Okada, Jun Tanaka, Tsuyoshi Oguma, Koichiro Asano
發表在 Scientific Reports (2023-04-01)獲取全文
Article -
7
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy foll... 由 Shigeru Tanzawa, Tomonori Makiguchi, Sadatomo Tasaka, Megumi Inaba, Ryosuke Ochiai, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Yosuke Miyamoto, Toshihide Yokoyama, Chiaki Matsumoto, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Toshihiro Misumi, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
發表在 Therapeutic Advances in Medical Oncology (2022-07-01)獲取全文
Article -
8
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI s... 由 Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
發表在 Therapeutic Advances in Medical Oncology (2022-12-01)獲取全文
Article
